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Abstract
Background: The G1 checkpoint is a critical regulator of genomic stability in untransformed cells, preventing cell
cycle progression after DNA damage. DNA double-strand breaks (DSBs) recruit and activate ATM, a kinase which in
turn activates the CHK2 kinase to establish G1 arrest. While the onset of G1 arrest is well understood, the specific
role that ATM and CHK2 play in regulating G1 checkpoint maintenance remains poorly characterized.
Results: Here we examine the impact of ATM and CHK2 activities on G1 checkpoint maintenance in untransformed
cells after DNA damage caused by DSBs. We show that ATM becomes dispensable for G1 checkpoint maintenance
as early as 1 h after DSB induction. In contrast, CHK2 kinase activity is necessary to maintain the G1 arrest,
independently of ATM, ATR, and DNA-PKcs, implying that the G1 arrest is maintained in a lesion-independent
manner. Sustained CHK2 activity is achieved through auto-activation and its acute inhibition enables cells to
abrogate the G1-checkpoint and enter into S-phase. Accordingly, we show that CHK2 activity is lost in cells that
recover from the G1 arrest, pointing to the involvement of a phosphatase with fast turnover.
Conclusion: Our data indicate that G1 checkpoint maintenance relies on CHK2 and that its negative regulation is
crucial for G1 checkpoint recovery after DSB induction.
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Background
The integrity of our genome is constantly challenged by
endogenous and exogenous insults that can cause dam-
age to the DNA [1]. Double-strand breaks (DSBs) are
considered the most detrimental type of lesion because
they are difficult to repair and can lead to chromosomal
rearrangements or losses of chromosome fragments [2].
Upon DSB induction, multiple cell cycle checkpoints en-
sure activation of the DNA damage response (DDR) to
regulate DNA repair and cell cycle progression in a co-
ordinated manner [3, 4]. In this sense, the cell must not
only trigger a cell cycle arrest when the damage has been
inflicted, but also maintain it while the lesion is being
repaired and resume cell cycle progression once the re-
pair is complete. DSBs generated by physical or chemical
agents such as ionizing radiation (IR) or neocarzinostatin
(NCS), activate the members of a family of phosphoino-
sitide 3-kinase (PI3K)-related kinases (PIKKs): the ataxia
telangiectasia mutated (ATM) kinase, the ATM- and
Rad3-related (ATR) kinase and the DNA-dependent pro-
tein kinase catalytic subunit (DNA-PKcs) [5]. Whereas
DNA-PKcs is mostly focused on promoting DSB repair,
ATM and ATR also regulate cell cycle progression,
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ATM being the main kinase activated by DSBs [6]. ATM
will phosphorylate histone H2AX in the vicinity of the
damaged site to recruit repair proteins [7], as well as
effector kinases to regulate cell cycle progression. The
main kinase downstream of ATM is the serine/threo-
nine-protein kinase CHK2, which is phosphorylated at
threonine 68 (T68) [8], a characteristic site that can be
used to measure cellular ATM activity [9]. This priming
phosphorylation promotes the dimerization and auto-
phosphorylation of CHK2 on several residues, including
serine 516 (S516), which is required for the optimal acti-
vation and function of this kinase [10, 11]. The hyper-
phosphorylated form of CHK2 is fully active and triggers
a downstream signaling cascade that activates and stabi-
lizes p53, leading to induction of its transcriptional
target p21CIP1, thus halting the cell cycle [12–15].
Checkpoint regulation largely depends on whether the
damage was inflicted in G1 or G2 phase of the cell cycle
[16]. Such dissimilar cell cycle responses might arise
from fundamental differences in the regulation of the
signaling pathways activated in G1 vs G2 cells upon
DNA damage, although there is some overlap in the
DDR signaling molecules. For instance, loss of either
p53 or p21 results in complete inactivation of the G1
checkpoint, but not the G2 checkpoint [16–18], suggest-
ing that only a G1 checkpoint-induced arrest is
dependent on both proteins. Regarding the kinases that
regulate checkpoint arrest after DNA damage, G2 relies
mainly on ATR- and CHK1-dependent signals [19, 20],
whereas G1 relies on ATM and CHK2 [9, 16]. Further-
more, life-cell imaging experiments show that untrans-
formed cells irradiated in G2 initiate a rapid cell cycle
arrest but lose their ability to recover within 1 day after
IR. Conversely, cells irradiated in G1 maintain a revers-
ible arrest for a much longer period of time, being able
to recover even 3 days after DSB induction [21]. How-
ever, the mechanisms by which cells achieve a prolonged
G1 arrest and the signals involved in recovery have not
been elucidated.
In this work, we have employed untransformed retinal
pigment epithelial (RPE-1) cells to examine G1 check-
point regulation after DSB induction. We have discov-
ered that while ATM phosphorylation is required for G1
checkpoint initiation, it becomes dispensable after as
early as 1 h following DNA damage. Instead, we present
evidence that G1 arrest maintenance relies on auto-
activation of CHK2. We have found that sustained
CHK2 self-activity is required for the prolonged arrest in
G1 and that CHK2 phosphorylation on S516 is lost as
cells recover from the damage, implying the activity of a
putative phosphatase with fast turnover. Thus, phos-
phorylation of CHK2 on S516 would function as a
critical switch controlling the timing for re-entry into
the S-phase of the cell cycle.
Results
Induction of double-strand breaks in G1 phase activates
ATM/CHK2/p53-dependent signaling responses and
triggers cell cycle arrest
In order to set up an experimental system to study DNA
damage-induced G1 checkpoint regulation, we made use
of untransformed, immortalized retinal pigment epithe-
lial cells (RPE-1), as they are p53-proficient and retain a
functional G1 checkpoint [21, 22]. A nearly pure G1 cell
population can be obtained after growing RPE-1 cells to
confluency to achieve contact inhibition, starving them
for around 36 h, and re-stimulating with serum for 4 h
(Additional file 1 Fig. S1a-b). Exposure of G1-
synchronized RPE-1 cells to ionizing radiation (IR) trig-
gered the formation of γH2AX and 53BP1 foci (Fig. 1a),
two well-characterized markers for DNA double-strand
breaks (DSBs). As expected, the high number of breaks
generated during the first hours after DSB induction
were rapidly repaired, with a minimum amount of
breaks remaining after 14 h of DNA damage induction
(Fig. 1a).
The downstream signaling cascade activated by DSBs
was detected by western blot. Exposure of G1-
synchronized RPE-1 cells to 2 and 4 Gy doses of IR
induced the phosphorylation of CHK2 in threonine 68
(T68) and serine 516 (S516) (Fig. 1b). These phospho-
sites are commonly used as specific readouts for ATM
and CHK2 activities, respectively, as evidenced by the
disappearance of T68 or S516 phosphorylation upon
pretreatment of irradiated cells with specific inhibitors
for either ATM or CHK2 activities (Additional file 1 Fig.
S1c-d). As shown in Fig. 1b, T68- and S516-
phosphorylation were high at 2 h after the damage and
could still be detected 16 h later, suggesting a rapid and
persistent activation of ATM and CHK2 upon damage.
In line with the wild-type p53 status of RPE-1 cells, the
levels of this protein showed an initial increase, evident
after 2 h post-damage, followed by a decrease at later
timepoints. Similarly, treatment of G1-synchronyzed
RPE-1 cells with various doses of neocarzinostatin
(NCS), a well-known radiomimetic drug that also gener-
ates DSBs, led to similar dynamics of ATM, CHK2, and
p53 activities (Fig. 1b).
To monitor the consequences of DSB induction on
cell cycle progression, G1-synchronized RPE-1 cells were
incubated with the thymidine analog BrdU to label S-
phase cells, by adding the compound at the same time of
IR or after the NCS pulse (Fig. 1c, upper panel). To
monitor the accumulation of S-phase cells after damage,
the Eg5-inhibitor STLC, which traps cells in mitosis
[23], was added concomitantly with BrdU (Fig. 1c, green
line). This ensures that all the BrdU-positive cells that
are computed derive from a single cell cycle progression
event. Forty hours after exposure to either IR or NCS, a
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dose-dependent decrease in BrdU incorporation was ob-
served, indicating that both treatments hampered the
progression into S-phase (Fig. 1c, lower panel).
Therefore, G1-synchronyzed RPE-1 cells activate the
ATM-CHK2-p53 axis and trigger a G1 arrest upon DSB
induction, making this experimental system very suitable
for the study of mechanisms of G1 checkpoint
regulation.
CHK2 kinase, but not ATM kinase, maintains G1
checkpoint arrest after DNA damage
Despite the well-established role of ATM and CHK2 ki-
nases in G1 checkpoint initiation, their contribution to
G1 checkpoint maintenance has not been explored in
detail. Making use of the experimental setup presented
in Fig. 1, we first assessed the kinetics of ATM and
CHK2 activities at short times after DNA damage by
monitoring the CHK2 T68 and S516 phosphosites. As
shown in Fig. 2a, both ATM and CHK2 are activated as
early as 10 min after irradiation, with ATM activity peak-
ing before CHK2 activity. We next verified that ATM
and CHK2 kinases function in initiating G1 checkpoint
signaling by inhibiting ATM or CHK2 activity just
before IR (0 h) in G1-synchronized RPE-1 cells. As
shown in Fig. 2b (left panel), ATM inhibition with a
specific inhibitor reduced T68 and S516 phosphoryl-
ation, indicating that it does not only abolish its own ac-
tivity, but also the activation of its downstream target
CHK2. By contrast, CHK2 inhibition with a specific in-
hibitor efficiently reduced its phosphorylation on S516
without disturbing ATM activity, as CHK2-T68 phos-
phorylation remained unaffected. Importantly, the
pharmacological inhibitors that were used to block ei-
ther ATM or CHK2 activities did not alter total CHK2
levels (Additional file 2 Fig. S2a).
Next, we evaluated the differential role of ATM and
CHK2 kinases on G1-checkpoint establishment by ana-
lyzing BrdU incorporation in the presence of STLC
(Fig. 2c, inhibitors at 0 h). Inhibition of either kinase
around 15min before IR (0 h) induced a near-complete
override of the G1 arrest, as evidenced by a nearly 60%
BrdU-positive cell population upon this treatment
(Fig. 2c). A different inhibitor (obtained from Apex-Bio)
led to similar results (Additional file 2 Fig. S2b). These
results are consistent with the role of ATM and CHK2
on G1 checkpoint establishment. To examine the role of
ATM and CHK2 kinases on G1 checkpoint mainten-
ance, the same inhibitors were added after 1 or 16 h of
IR treatment. Strikingly, inhibition of ATM at these time
points no longer resulted in a reduction in CHK2 activa-
tion status, as evidenced by sustained phosphorylation
on the S516 autophosphorylation site (Fig. 2b, middle
and right panels). This indicates that CHK2 activity is
uncoupled from its upstream activator ATM as early as
Fig. 1 Double-strand break (DSB) induction in G1 by irradiation
activates ATM/CHK2/p53-dependent signaling and triggers cell cycle
arrest. a RPE-1 cells were fixed at the indicated times after 4 Gy IR.
EdU was added at the time of IR and cells were stained for EdU
using Click-iT chemistry after IF for DAPI, γH2AX, and 53BP1. The
number of γH2AX and 53BP1 foci per nucleus was counted with an
in-house developed macro in G1 cells, which were identified by the
nuclear size (small DAPI intensity) and absence of EdU staining. b
G1-synchronized RPE-1 cells were left untreated (0 Gy) or treated
with two IR doses (2 Gy, 4 Gy), or four NCS doses (10, 20, 40, 80 ng/
ml); protein was collected 2 or 16 h after DNA damage for the
detection of the indicated proteins by western blot. Phosphorylation
of CHK2 on T68 and S516 are indicative of active ATM and CHK2
kinases; increased p53 proteins levels are indicative of stabilized and
active p53; CDK4 served as a loading control. c G1-synchronized
RPE-1 cells were treated as in b; BrdU and STLC were added at the
time of IR/NCS, and cells were collected by trypsinization 40 h later
for flow cytometry analysis (upper panel). The percentage of BrdU-
positive cells is indicative of the percentage of cells that have
entered into S-phase, and decreases with IR in a dose-dependent
manner. Depicted are the means and standard deviation of three
independent experiments (lower panel)
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Fig. 2 Once initiated by ATM, CHK2 kinase maintains G1 checkpoint arrest after DNA damage. a G1-synchronized cells were irradiated, and
protein was harvested at the indicated timepoints after the damage for western blot analysis of CHK2 T68 and S516 phosphosites. b G1-
synchronized RPE-1 cells were left unirradiated (0 Gy) or irradiated (4 Gy); irradiated cells were left untreated (UT) or treated with inhibitors for
ATM (ATMi) or CHK2 (CHK2i) at the indicated times (0, 1, 16 h) and protein was harvested 1 h later (1, 2, 17 h post-damage, hpd) for western blot
analysis. HSP90 served as a loading control. c G1-synchronized RPE-1 cells were treated as in b, BrdU and STLC were added at the time of IR, and
cells were collected by trypsinization 40 h later for flow cytometry analysis of BrdU-positive (S-phase) cells (upper left part). In the right part, BrdU/
propidium iodide plots of each experimental condition of a representative experiment are shown. In the lower left part, a bar graph represents
the means and standard deviation of three independent experiments. d G1-synchronized RPE-1 cells were left unirradiated (0 Gy) or irradiated (4
Gy); irradiated cells were left untreated or treated with CHK2i at the indicated times (0, 1, 16 h) and protein was harvested 1 h later (1, 2, 17 hpd)
for western blot analysis
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1 h after the damage is inflicted. Interestingly, this un-
coupling seems to be particularly effective in G1-
arrested cells, but not in G2-arrested cells, as inhibition
of ATM 1 h after IR in a G2-synchronized RPE-1 cell
population (Additional file 2 Fig. S2c-d) caused a clear
decrease in pCHK2 S516 levels compared to the un-
treated control (Additional file 2 Fig. S2e).
Strikingly, BrdU incorporation analyses showed that
addition of CHK2 inhibitor after 1 or 16 h following IR
was unable to impose G1 arrest as cells entered S-phase
very efficiently; by contrast, ATM inhibition failed to ab-
rogate the G1 arrest (Fig. 2c). These results reveal a
major role for CHK2 kinase, but not for ATM, in the
maintenance of a DNA damage-induced G1 arrest. As
expected, p53 was upregulated shortly after DNA dam-
age was inflicted (1 and 2 h after IR), a raise that was
followed by p21 induction. Importantly, the fast accumu-
lation of p53 and p21 levels observed 2 h after IR was
partially prevented by CHK2 inhibitor treatment
(Fig. 2d).
Notably, in contrast to G1, pharmacological inhibition
of CHK2 in G2-synchronized RPE-1 cells was not suffi-
cient to induce a clear checkpoint recovery (Additional
file 2 Fig. S2f), as previously reported [24]. This is likely
due to the fact that end-resection is more active in G2
cells, causing co-activation of ATR and CHK1. Nonethe-
less, these data clearly indicate that CHK2 kinase plays a
distinct role in G1 checkpoint regulation. Altogether,
our findings suggest that while ATM and CHK2 activ-
ities are required for a G1 checkpoint establishment,
once initiated, ATM becomes dispensable for further ac-
tivities, and checkpoint maintenance mainly relies on
CHK2 kinase. This raises the intriguing possibility that
CHK2 auto-activation is sufficient to maintain a
checkpoint-induced arrest in G1, something that could
be achieved independently of the persistence of the le-
sion that produced its activation.
CHK2 kinase maintains its own activity independently of
ATM, ATR, and DNA-PKcs
Even though ATM is the main kinase that phosphory-
lates CHK2 on T68, triggering its activation, two other
template-dependent kinases, namely ATR and DNA-
PKcs, have been reported to phosphorylate CHK2 on the
same residue in vitro [25–27]. We therefore tested the
impact of ATR or DNA-PKcs kinases in the regulation
of G1 checkpoint signaling in our cellular system. For
that purpose, we made use of specific inhibitors for ATR
(Additional file 3 Fig. S3a) and DNA-PKcs (Additional
file 3 Fig. S3b).
To evaluate their role in checkpoint establishment, we
added inhibitors of these kinases, alone or in combin-
ation, just before IR (0 h) to G1-synchronized RPE-1
cells. As shown in Fig. 3a, only the inhibition of ATM
could efficiently reduce the levels of the priming T68
phosphosite. By contrast, specific inhibition of ATR or
DNA-PKcs did not prevent phosphorylation of CHK2
on T68 or on S516 in our cellular system. Furthermore,
only ATM inhibition at the time of IR could fully pre-
vent the activation of CHK2, as judged by the absence of
S516 phosphorylation upon ATM inhibitor treatment.
These results suggest that ATM is the major upstream
kinase that triggers the activation of CHK2 in G1-
synchronized RPE-1 cells.
Next, we wondered whether, once the G1 checkpoint
has been initiated, any of these template-dependent ki-
nases could phosphorylate CHK2, and keep its activity.
Fig. 3 CHK2 kinase maintains its own activity independently of ATM,
ATR, and DNA-PKcs after DNA damage in G1. a G1-synchronized
cells were left unirradiated (0 Gy) or irradiated (4Gy); irradiated cells
were either left untreated (−) or treated (+) with inhibitors for ATM
(ATMi), ATR (ATRi), or DNA-PKcs (DNA-PKi) kinases alone or in
combination at the time of IR (0 h) and protein was harvested 1 h
later (1 h post-damage, hpd) for western blot analysis. b Cells were
treated as in a, but inhibitors were added 1 h after IR and harvested
2hpd (upper panel) or 16 h after IR and harvested 17hpd (lower
panel). CDK4 served as a loading control for all experiments
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For this purpose, we treated cells with specific inhibitors
of ATM, ATR, or DNA-PKcs kinases after 1 or 16 h fol-
lowing IR, and checked CHK2 phosphorylation levels. We
confirmed that CHK2 T68 phosphorylation, but not S516
phosphorylation, was prevented upon ATM inhibition
(Fig. 3b). Furthermore, inhibition of ATR and DNA-PKcs,
either alone or in combination, did not prevent phosphor-
ylation of T68 or S516 sites on CHK2 (Fig. 3b). These data
suggest that the template-dependent kinases ATM, ATR,
and DNA-PKcs are dispensable for maintaining CHK2 ac-
tivity in G1-arrested cells.
CHK2 self-activation is critical to sustain the G1 arrest
induced by DNA damage
Once phosphorylated in T68, CHK2 dimerizes and auto-
phosphorylates to become fully active [10, 11]. We hy-
pothesized that by doing so CHK2 could continue to
self-activate in an ATM-independent manner once the
G1 arrest was established. We first tested this hypothesis
by continuously exposing irradiated cells to ATMi and
checking phosphorylated S516 CHK2 levels. As shown
in Fig. 4a, treatment of irradiated cells with ATM inhibi-
tor for an extended period after damage abolished T68
phosphorylation, but did not affect S516 phosphoryl-
ation of CHK2. Next, we irradiated G1-synchronized
RPE-1 cells and 1 h later they were treated with either
CHK2 inhibitor alone (CHK2i), or with a combination of
CHK2 and ATM inhibitors (CHK2iATMi) (Fig. 4b,
upper panel). After a pulse of 1 h, the inhibitors were
washed out, and cells were incubated for two additional
hours in the absence or presence of ATM inhibitor be-
fore protein harvest, in order to evaluate whether CHK2
phosphorylation in T68 might have any impact in its au-
tophosphorylation capacity (Fig. 4b, upper panel). Strik-
ingly, after inhibitor release, both T68 and S516 sites
were readily re-phosphorylated almost to the level of the
untreated cells, both in cultures treated with CHK2i as
well as in cultures treated with CHK2iATMi. By contrast,
the presence of ATM inhibitor in the media prevented
T68 phosphorylation but not S516 phosphorylation of
CHK2 (Fig. 4b, lower panel, 4hpd). The experiment was
repeated at longer times after DNA damage, obtaining
similar results (Additional file 4 Fig. S4). Overall, these
data suggest that CHK2 might be responsible for keeping
its own activity independently of ATM.
We next wondered whether re-activation of CHK2
was sufficient to arrest damaged cells in G1. To test this
hypothesis, cells that were treated with inhibitors of
CHK2 or CHK2 and ATM for an hour were further in-
cubated in the presence of BrdU and STLC as previously
explained. These cells showed the same level of G1 ar-
rest as those that had not been treated with the kinase
inhibitors (Fig. 4c), suggesting that re-activation of
CHK2 was enough to re-establish an arrest in G1.
Additionally, we tested whether a longer pulse of
CHK2 inhibitor or a combination of CHK2 and ATM
inhibitors could render CHK2 inactive. The experiment
was repeated by applying a 3-h inhibitor pulse, followed
by 1-h release without inhibitors, or in the presence of
either ATM inhibitor or a combination of ATM, +ATR,
and +DNA-PKcs inhibitors. In line with the previous ex-
periment results, CHK2 was readily re-phosphorylated
in all conditions (Fig. 4d), and this re-phosphorylation
was enough to re-establish a cell cycle arrest (Fig. 4e).
These results underscore the importance of an active
CHK2 autophosphorylation loop to achieve a robust G1
checkpoint arrest.
Inhibition of protein synthesis affects CHK2 S516
phosphorylation levels
CHK2 is S516-phosphorylated and active for a relatively
long time after DNA damage in G1, in part because of
its ability to undergo autophosphorylation. To search for
additional mechanisms that may retain CHK2 activity,
we evaluated the stability of CHK2 in NCS-treated G1
RPE-1 cells in the presence of cycloheximide (CHX), an
inhibitor of protein synthesis commonly used for protein
stability measurements (Fig. 5a, upper panel). The level
of total CHK2 did not vary upon CHX treatment, in
contrast to CYCLIN D1, a protein known to have a short
half-life [28]. These results suggest that CHK2 is a stable
protein with a slow turnover in RPE-1 cells. Strikingly,
CHX treatment caused the accumulation of pCHK2
S516 in NCS-treated cells, while it had no effect in un-
treated conditions. Measurement of pCHK2 S516 over
total CHK2 levels in four independent experiments
shows a tendency of pCHK2 S516 accumulation upon
protein synthesis inhibition in DNA damaging condi-
tions, especially when compared with the clear decrease
of CYCLIN D1 levels (Fig. 5a, lower panel). The accu-
mulation of S516 when protein synthesis inhibition is
blocked is consistent with the auto-phosphorylating cap-
acity of CHK2. Moreover, these data suggest that the re-
moval of pCHK2 S516 phosphorylation, required to
disrupt the self-activation loop in CHK2, is dependent
on continued new protein synthesis.
To extend these experiments, we treated G1-
synchronyzed RPE-1 cells with the proteasome inhibitor
MG132 in the presence or absence of NCS. As shown in
Fig. 5b, MG132 treatment did not alter total CHK2
levels, in contrast to CYCLIN D1, which accumulated
after proteasome inhibition. Strikingly, pCHK2 S516
levels were slightly reduced in MG132-treated cells after
DNA damage in three independent experiments. These
results are consistent with our previous experiment and
suggest that a CHK2 phosphatase with fast turnover
could be regulating CHK2 activity, a possibility that
should be further validated.
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Loss of CHK2 S516 phosphorylation is required to recover
from a prolonged DNA damage-induced arrest in G1
We next assessed the kinetics of recovery for cells that
have been G1-arrested upon DNA damage, and analyzed
the role of CHK2 S516 in this process. To this end, G1-
synchronized RPE-1 cells were cultured for up to 6 days
in the presence of BrdU and STLC and were harvested
every 24 h. Flow cytometry analyses show that cells con-
tinued to enter into S-phase for the duration of the ex-
periment, suggesting that G1 cells maintain the recovery
competence for at least 6 days after the damage (Fig. 6a).
We selected early and intermediate timepoints to assess
in detail the status of CHK2 phosphorylation in cells
undergoing recovery. RPE-1 cells irradiated with a dose
Fig. 4 CHK2 self-activity after DNA damage enables G1 arrest establishment independently of ATM. a Left panel: experimental setup. G1-
synchronized RPE-1 cells were irradiated with a dose of 4 Gy, and 1 h after cells were either left untreated (−ATMi) or treated with ATM inhibitor
(+ATMi); protein was harvested at the indicated timepoints. Right panel: western blot analysis of protein extracts. b Upper panel: experimental
setup. G1-synchronized RPE-1 cells were irradiated with a dose of 4 Gy, and 1 h after IR inhibitors for either CHK2 alone (CHK2i, blue line) or CHK2
and ATM (CHK2iATMi, blue and red line) were added; 1 h later (2 h timepoint) inhibitors were washed out, and cells were incubated in the
absence (−ATMi, black line) or presence (+ATMi, red line) of ATM inhibitor for two additional hours (4 h timepoint). Lower panel: western blot
analysis of protein extracts from 2 h and 4 h timepoints. c Cells treated as in b were cultured for 40 h with BrdU/STLC in the presence or absence
of ATMi during inhibitor release and collected by trypsinization for flow cytometry analysis; a condition where inhibitors were added at the time
of IR (0 h) and maintained until trypsinization was used as a control for G1 recovery. Depicted are the means and standard deviation of three
independent experiments. d Upper panel: the experiment in b was repeated with an CHK2i or CHK2iATMi pulse of 3 h and 1 h release in the
absence of inhibitors (−Inhibitors, black line), presence of ATM inhibitor (+ATMi, red line) or presence of ATM, ATR, and DNA-PKcs inhibitors
(+ATMi+ATRi+DNAPKi, purple line). Lower panel: western blot analysis of protein extracts of 4 and 5 h post-damage (hpd). e Cell cycle analysis of
cells treated as in d, and cultured in the presence of BrdU/STLC during inhibitor release
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of 4 Gy revealed that CHK2 phosphorylation on S516 was
detectable for as long as 40 h after the damage (Fig. 6b), in
line with the results presented in Fig. 4a. Given that at this
timepoint a fraction of the cells has already recovered
from the checkpoint imposed at G1, we examined
S516 phosphorylation status of CHK2 using RPE-
Fucci cells [29]. RPE-Fucci cells can be sorted using
fluorescence-activated cell sorting (FACS); cells ex-
pressing red fluorescent mKO2-Cdt1 correspond to
the G1-arrested cells, and cells expressing green fluor-
escent mAG-Geminin correspond to cells that recov-
ered and had entered the cell cycle (Fig. 6c). Analysis
of CHK2 phosphorylation status in RPE-Fucci cells ir-
radiated with 4Gy revealed that while CHK2 remained
phosphorylated at S516 up to 40 h in arrested cells,
this phosphorylation was completely absent in recov-
ered cycling cells (Fig. 6d), suggesting that loss of
CHK2 phosphorylation at S516 is necessary to recover
from a G1 arrest imposed upon DNA damage.
Discussion
G1 checkpoint is important for cells that encounter
DSBs and can be maintained for several days follow-
ing the damage. However, little is known about the
molecular mechanisms that regulate G1 checkpoint
maintenance, partly because most cancer cell lines
used in research carry genetic alterations in p53 that
render G1 checkpoint non-functional [30–32]. Our
aim has been to evaluate the role that ATM and
CHK2, the two main kinases activated upon DSB in-
duction in G1, play in G1 checkpoint maintenance.
By using p53-proficient untransformed cells that en-
able sharp G1 synchronization, efficient DSB induc-
tion, reliable measurements of ATM and CHK2
activities, and easy monitoring of cell cycle progres-
sion, we present evidence that ATM and CHK2 play
distinct roles in G1 checkpoint regulation.
A compelling finding presented here is that ATM ac-
tivity becomes dispensable for G1 arrest maintenance
very shortly after the damage has been inflicted. It has
been described that inhibition of ATM at relatively long
timepoints after DNA damage (16 h) did not have any
impact in cell cycle regulation [22]. We have now deter-
mined that the uncoupling of ATM activity occurs as
early as 1 h after damage induction and that CHK2 ac-
tivity is maintained even in the continuous presence of
ATM inhibitor. This implies that ATM serves mainly as
a switch to initiate G1 checkpoint signaling, but subse-
quent maintenance of the arrest and control of the re-
covery largely depends on auto-activation of its direct
Fig. 5 Inhibition of protein synthesis affects CHK2 S516 phosphorylation levels. a G1-synchronized RPE-1 cells were left untreated (UT) or treated
with a dose of 40 ng/ml of neocarzinostatin (NCS40) for 30 min; around 16 h after DNA damage, cycloheximide (CHX) was added at the indicated
times before protein harvest. A representative western blot is shown (upper panel) together with the quantifications of four independent
experiments (lower panel). b RPE-1 cells were treated as in a, but instead of using CHX, the MG132 was added at the indicated times before
protein harvest. A representative western blot is shown (upper panel) together with the quantifications of three independent experiments (lower
panel). In both quantifications, pCHK2 S516 levels where relativized with total CHK2 (blue lines), while cyclin D1 levels were relativized with HSP90
(green lines); only NCS-treated conditions were quantified. Error bars indicate standard deviations
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target CHK2. Given the key role that CHK2 activity
plays in G1 arrest maintenance, CHK2 S516, rather than
T68, would be a more suitable marker for G1 checkpoint
activity.
We have found that, unlike ATM, CHK2 activity is
critical to maintain cell cycle arrest both at early and
long timepoints after DSB induction in G1 cells. This is
in contrast to the observation that CHK2 inhibition does
not abrogate G2 checkpoint induced by UV-inflicted
DNA damage [24]. Actually, in G2 phase of the cell
cycle, another lesion-dependent kinase, ATR, is primar-
ily activated, and its preferential downstream kinase is
CHK1 [33, 34]. Thus, even though G1 and G2 check-
points share a number of molecular mediators, their
regulation appears to be different in each case [16, 22].
These differences in G1 vs G2 checkpoint regulation are
paralleled by different kinetics of CHK2 S516 phosphor-
ylation in each checkpoint. In agreement with previous
reports, sustained ATM to CHK2 signaling helps to
maintain phosphorylated CHK2 levels in G2, since ATM
inhibition after initial CHK2 activation results in dimin-
ished levels of phosphorylated CHK2 [35]. In contrast,
we have shown that in G1, CHK2 activity is independent
of ATM, ATR, and DNA-PKcs template-dependent ki-
nases at early and even relatively long timepoints after
the damage. In fact, at the long timepoints assessed in
our work (14–16 h post-damage), the majority of DNA
breaks are already resolved, suggesting the existence of a
“template-independent” DDR in G1. Thus, we speculate
that the cell must have an independent mechanism that
allows reading for the decay in breaks, opening the door
for future research in the field of DNA damage
response.
Once primed on T68 by ATM, CHK2 keeps its
own phosphorylation and activity by different mecha-
nisms. One of them relies on the autophosphorylation
Fig. 6 Loss of CHK2 activity is required to recover from a DNA
damage-induced arrest in G1. a G1-synchronized RPE-1 cells were
irradiated with a dose of 4 Gy; at the same time, BrdU and STLC
were added and trypsinized at the indicated days after IR for flow
cytometry analysis of BrdU-positive cells. Irradiated cells progressively
entered into S-phase up to 6 days after IR. Depicted are the means
and standard deviation of five independent experiments. b G1-
synchronized RPE-Fucci cells were left unirradiated (−) or irradiated
with a dose of 4 Gy (+); protein was harvested at the indicated
hours post-damage (hpd) and analyzed by western blot. HSP90 was
used as a loading control. IR induced a robust phosphorylation of
CHK2 at S516 that decreased over time. c RPE-Fucci cells were
trypsinized 40 hpd and arrested (expressing a red fluorofore) vs
recovered (expressing a green fluorofore) cells were isolated using
Fluorescence Activated Cell Sorting for subsequent western blot
analysis. FACS plot indicates the gating windows of arrested (red)
and recovered (green) cells. d Western blot analysis of arrested (A)
vs recovered (R) cells 40 h after irradiation; pCHK2 S516
phosphorylation is lost in cells that recovered from IR
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capacity of the kinase that, independently of T68
phosphorylation, enables to maintain CHK2 in a
hyperphosphorylated state, as has been previously
shown [36]. In our work, we demonstrate that the
self-phosphorylating capacity of CHK2 is sufficient to
re-establish a G1 arrest, highlighting the importance
of autophosphorylation not only for sustained CHK2
activity but also for appropriate G1 checkpoint regu-
lation. According to our data, another mechanism
that might be keeping CHK2 activity is the presence
of a yet unidentified phosphatase with fast turnover,
as evidenced by the accumulation of CHK2 S516
upon CHX treatment.
Finally, our data clearly shows that CHK2 S516 phos-
phorylation is lost in cells that recover from DNA
damage-induced G1 arrest, suggesting that a yet uniden-
tified phosphatase might promote G1 checkpoint
recovery. Among the phosphatases that could dephos-
phorylate CHK2, WIP1 has been shown to inhibit CHK2
kinase activity by dephosphorylating the T68 residue but
no effect on the S516 residue has been reported [37, 38].
Furthermore, in agreement with our evidence that
CHK2 activity is maintained independently of T68 phos-
phorylation by ATM in G1, WIP1 is only required for
cell cycle re-entry in G2, but not in G1 cells [22]. Never-
theless, we still lack many pieces of the puzzle to
propose a mechanism for CHK2 inactivation. Thus, fur-
ther studies are required to identify the phosphatase ac-
tivity responsible for CHK2 dephosphorylation and
inactivation in G1 after DNA damage recovery.
Conclusions
Taken together, our data underscore the essential role of
CHK2 activity in G1 arrest maintenance and provide in-
sights into the mechanism by which regulation of CHK2
S516 phosphorylation constitutes a critical step for G1
checkpoint decisions.
Methods
Cell culture, synchronization, and DSB induction
hTert-immortalized retinal pigment epithelial (RPE-1)
cells were maintained in Dulbecco’s Modified Eagle’s
medium/Nutrient Mixture F12 (DMEM F-12, Gibco)
supplemented with fetal calf serum (FCS, 6%) and
penicillin/streptomycin (1%) at 37 °C with 5% CO2. The
RPE-Fucci cell line was constructed as previously de-
scribed [22].
For G1 synchronization, RPE-1 cells grown to con-
fluency were seeded onto appropriate wells/plates, and
were left until they attach for at least 4 h. Subsequently,
cells were washed three times with phosphate-buffered
saline (PBS), and fresh serum-free medium was added
before incubation for additional 36 h for G0 establish-
ment. In order to induce re-entry into the cell cycle,
medium was replaced with 6% FCS-containing growth
medium, and cells were incubated for 4 h, a timepoint
where the majority of the cells are in G1 phase, before
the G1/S checkpoint (Additional file 1 Fig. S1a-b). For
G2 synchronization, RPE-1 cells were seeded, left until
they attach, and incubated with thymidine for 24 h
followed by a 7-h release, a timepoint where the majority
of the cells are in G2 phase, before the G2/M checkpoint
(Additional file 2 Fig. S1c-d).
Synchronized cells were either γ-irradiated (2–4 Gy)
using a Gammacell Extractor (Best Theratronics) with a
cesium-137 source, or left unirradiated; alternatively,
cells were treated with a pulse of neocarzinostatin for
30 min and washed two times with PBS (Note: the irradi-
ation/NCS treatment time is considered as the 0 h time-
point in all the experiments, as shown in Fig. 1c).
Chemicals and antibodies
The chemicals used for this study were the following:
ataxia telangiectasia mutated inhibitor (ATMi; KU55933,
10 μM; Sigma-Aldrich), ATM- and Rad3-related inhibi-
tor (ATRi, VE-821, 5 μM; Selleckchem), DNA-PKcs in-
hibitor (NU7441, 1 μM; Cayman Chemicals), CHK2
inhibitor II (CHK2i; 10 μM; Sigma-Aldrich), thymidine
(2.5 mM, Sigma-Aldrich), neocarzinostatin (NCS, 40–80
ng/ml; Sigma-Aldrich), 5-bromo-2′-deoxyuridine (BrdU,
10 μM; Sigma-Aldrich), (+)-S-Trityl-L-cysteine (STLC,
20 μM; Sigma-Aldrich), 5′-ethynyl-2′-deoxyuridine
(EdU, 20 μM; Thermo Fisher Scientific), propidium iod-
ide (PI, Sigma-Aldrich), RNAse A (Sigma-Aldrich), cy-
cloheximide (CHX, 10 μg/ml; Sigma-Aldrich), and
MG132 (5 μM; Sigma-Aldrich).
The following primary antibodies were used: anti-
pS139-H2AX (#05–636, Millipore), anti-53BP1 (sc-
22760, Santa Cruz), anti-phospho-CHK2 T68 (2661S;
Cell Signaling), anti-phospho-CHK2 S516 (2669S; Cell
Signaling), anti-total-CHK2 (sc-9064; Santa Cruz); anti-
p53 (sc-126; Santa Cruz), anti-p21 (sc-397, Santa Cruz),
anti-CYCLIN D1 (sc-718; Santa Cruz), anti-HSP90
(sc7947 & sc-13119; Santa Cruz), anti-CDK4 (C-22;
Santa Cruz), anti-BrdU (ICR1; Abcam), anti-pMPM2
(05-368; Millipore). The following secondary antibodies
were used: peroxidase-conjugated goat anti-rabbit and
goat anti-mouse antibodies (DAKO & Jackson laborator-
ies), and Alexa Fluor (AF)-conjugated secondary anti-
bodies (Molecular Probes).
Immunofluorescence
Cells grown onto coverslips were fixed at the indicated
timepoints after IR in PBS-buffered 3.7% formaldehyde
(Sigma-Aldrich), permeabilized with 0.5% Triton-X100
(Sigma-Aldrich) and blocked 3% BSA in PBS before pri-
mary and fluorescence-conjugated secondary antibody
incubation for immunofluorescence. Incorporated EdU
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was visualized using click chemistry [100 mM Tris (pH
8.5), 100mM ascorbic acid, 1 mM CuSO4, 1:4000 Alexa
Fluor 488-azide (Thermo Fisher Scientific)] as previously
described [22]. Nuclei were counterstained with 4′,6-dia-
midino-2-phenylindole (DAPI; Sigma-Aldrich). Cover-
slips were mounted in Vectashield (Vector Laboratories).
Images were taken using a Leica SP5 confocal micro-
scope, and the amount of IR-induced foci were counted
by a custom-written ImageJ macro that enabled auto-
matic and objective analysis of the foci as previously
described [39]. The updated version of the macro is
available at the GitHub repository (https://github.com/
bvandenbroek/nuclear_foci). G1/S cells were differenti-
ated from G2 cells based on total DAPI intensity, and S-
phase cells were identified by EdU-positivity. Thus, G1
cells were those that showed smaller DAPI intensity and
were negative for EdU.
Western blot
Cells were harvested and lysed using Laemmli buffer
(120 mM Tris (pH 6.8), 4% SDS, 20% glycerol). Protein
concentration was determined by Lowry method. Equal
amounts of proteins were separated by SDS-PAGE,
transferred to nitrocellulose membranes, and blocked in
3% bovine serum albumin (BSA, Sigma-Aldrich) in
TTBS. Membranes were stained with the indicated anti-
bodies and visualized using an enhanced chemilumines-
cence detection system. Band intensities were quantified
with ImageJ. Uncropped western blots are shown in
Additional file 5 Fig. S5.
Flow cytometry
For flow cytometry analysis of G1 recovery, BrdU and
STLC drugs were added just after irradiation (0 h time-
point). BrdU is a thymidine analog that labels S-phase
cells, and STLC is a mitotic trap that prevents cells from
entering into the next cell cycle round. Both BrdU and
STLC were kept in culture from the time of IR until cell
harvest. At the indicated timepoints, cells were trypsi-
nized and fixed in − 20 °C 70% ethanol. Following treat-
ment with 2M hydrochloric acid and 0.1% Triton-X100,
cells were stained with anti-BrdU and Alexa Fluor 647-
coupled goat anti-rat, and anti-pMPM2 and Alexa Fluor
488-coupled goat anti-mouse antibodies, followed by
propidium iodide and RNase A incubation. Data from at
least 10,000 cells were collected on a Becton Dickinson
FACSCalibur flow cytometer, and the percentage of
BrdU-positive cells was analyzed by CellQuest software
(Becton Dickinson). For analysis of G2 recovery, the
same procedure was repeated in G2-synchronized cells,
and the percentage of BrdU-negative and pMPM2-
positive (mitotic cell readout) cells was analyzed.
Fluorescence-activated cell sorting (FACS)
G1-synchronized RPE-Fucci cells were either irradiated
or left unirradiated, and subsequently grown in the pres-
ence of STLC. At the indicated timepoints, cells were
trypsinized and resuspended in growth medium diluted
in PBS (1:3 dilution) for sorting using a Becton Dickin-
son FacsAria Sorter. G1-arrested (red) vs recovered
(green) cells were sorted based on Kusabira-Orange
(KO) or Azami-Green positive signal. Cells were pelleted
by centrifugation and lysed in Laemmli buffer for pro-
tein isolation and subsequent western blot analysis as
described above.
Supplementary Information
The online version contains supplementary material available at https://doi.
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Additional file 1: Fig. S1. G1 cell cycle synchronization and controls of
ATM and CHK2 inhibitors. a RPE-1 cells were grown to confluency until
they achieved contact inhibition; confluent cells were seeded, allowed to
attach for 4 hours, washed three times with PBS and left cultures in star-
vation media for at least 36 hours for G0 establishment. Cells were re-
stimulated with serum-containing medium for 4 hours to obtain a G1-
enriched population. b G1 cells were collected by trypsinization, stained
with propidium iodide (PI) and analyzed by flow cytometry. PI profile
shows that 90% of RPE-1 cells are in G1 phase after the synchronization
protocol. c RPE-1 cells irradiated with a dose of 4 Gy were left untreated
or pre-treated with ATM inhibitor (ATMi) before IR; cells were harvested 1
hour after IR. Cells treated with ATMi show lower pCHK2 T68 levels, simi-
lar to the non-irradiated counterparts (0 Gy), indicating that pCHK2 T68
phosphosite is a good readout for ATM activity. d RPE-1 cells irradiated
with a dose of 4 Gy were left untreated or pre-treated with CHK2 inhibi-
tor (CHK2i) before IR; cells were harvested 1 hour after IR. Cells treated
with CHK2i show lower pCHK2 S516 levels, similar to the non-irradiated
counterparts (0 Gy), indicating that pCHK2 S516 phosphosite is a good
readout for CHK2 activity.
Additional file 2: Fig. S2. CHK2 activity is required to maintain cell
cycle arrest after DSB induction in G1, but not in G2. a RPE-1 cells irradi-
ated with 4 Gy and treated with specific inhibitors for ATM and CHK2
show similar levels of total CHK2 protein. b Left panel: G1-synchronized
RPE-1 cells were irradiated (4 Gy) and treated with the indicated doses of
either CHK2i-II or CHK2i from Apex-Bio for one hour; protein extracts
were analyzed by western blot. Right panel: G1 cells treated as in b with
10 µM and 0.5 µM concentrations of CHK2i-II or CHK2i-Apex-Bio, respect-
ively, were further incubated with BrdU/STLC, and BrdU incorporation
was analyzed by flow cytometry. c G2-synchronization protocol. Asyn-
chronous RPE-1 cells were seeded, allowed to attach for approximately
24 hours, and blocked in the G1/S boundary with thymidine for 24 hours;
cells were released for 7 hours to obtain a G2-enriched population. d PI
profile of G2 cells shows that 90% of RPE-1 cells are in G2 phase after the
synchronization protocol. e G2-synchronized RPE-1 cells were left unirra-
diated (0 Gy) or irradiated (4 Gy); irradiated cells were left untreated (UT)
or treated with inhibitors for ATM (ATMi) or CHK2 (CHK2i) at the indicated
times (0 or 1 hour after IR) and protein was harvested at 2 hours post-
damage timepoint for western blot analysis. CDK4 served as a loading
control. f G2-synchronized RPE-1 cells were treated with CHK2i or ATRi
(positive control); BrdU and STLC were added at the time of IR, and cells
were collected by trypsinization for flow cytometry analysis of mitotic
cells that were in G2 at the time of IR (BrdU-negative/MPM2-positive).
Statistical analysis was carried out using one-way ANOVA (n.s.: non-
significant; **p<0.01).
Additional file 3: Fig. S3. Controls for ATR and DNA-PKcs inhibitors
used in the present work. a RPE-1 cells were treated with hydroxyurea
(HU) to induce ATR activation, or pre-treated with ATR inhibitor before
HU treatment. Protein was harvested, and ATR activation status was
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checked by western blot using pCHK1 S345 phopshosite as a readout.
CDK4 served as a loading control. ATRi effectively prevented HU-induced
pCHK2 phosphorylation. b G1-synchronized RPE-1 cells grown onto cov-
erslips were irradiated (4 Gy), and fixed for γH2AX and DAPI staining at
the indicated timepoints; one sample was pretreated with DNA-PKcs in-
hibitor. Treatment with DNA-PKcsi prevented the foci resolution observed
at 40 hours post-damage.
Additional file 4: Fig. S4. CHK2 self-activity at long timepoints after
DNA damage enables G1 arrest establishment. Upper panel: experimental
setup. G1-synchronized RPE-1 cells were irradiated with a dose of 4 Gy,
and 16h after IR inhibitors for either CHK2 alone (CHK2i, blue line) or
CHK2 and ATM (blue and red line) were added; one hour later (17h time-
point) inhibitors were washed out, and cells were incubated in the ab-
sence (-ATMi, black line) or presence (+ATMi, red line) of ATM inhibitor
for two additional hours (19 h timepoint). Lower panel. western blot ana-
lysis of protein extracts from 17h and 19h timepoints; left panel corre-
sponds to cells treated with CHK2i alone, and right panel to cells treated
with a combination of CHK2i and ATMi.
Additional file 5: Fig. S5. Uncropped western blots.
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